Home > Resources > Whitepapers > A Guide to Current Therapies in Immuno-Oncology

A Guide to Current Therapies in Immuno-Oncology

June 2, 2019

The global immuno-oncology market is expected to reach $128.3 billion by 2024. What breakthroughs have led to these incredible developments and where are we going? Take a ride on this amazing journey and download our beautiful white paper we created with the experts at Cisbio to discover the past and present of immuno-oncology therapy as well as its exciting future.

Spotlight

NES Healthcare UK

NES Healthcare has been established for over 25 years. We are the UK’s largest provider of Medical Officers to the Independent Healthcare Sector (private hospitals). We employ over 200 doctors from all over the world, and we currently work with over 100 hospitals and clinics to provide the highest level of patient care. In addition to the Resident Medical Officer (RMO) position, we offer a number of Specialist positions which offer good salaries and opportunities for a better work/life balance.

OTHER WHITEPAPERS

Considerations for migrating a drug product presentation from vial to pre-filled syringe

whitePaper | December 9, 2022

There is an upward trend for pharmaceutical companies to ask their contract development and manufacturing organisations (CDMO).

Innovative strategies to maintain product integrity in Biologic andBiosimilar clinical studies

whitePaper | August 7, 2022

The number of biologic new molecular entities approved by the FDA has increased over the last five years indicates a growing focus on biosimilar.

Biopharmaceutical Sector

whitePaper | May 29, 2023

tronger than expected US inflation and a bump in consumer spending have fuelled worldwide expectations that interest rates will go higher, as predictions about future monetary policy rapidly shift.

Imaweld® heat sealable & weldable tube bioprocess media

whitePaper | February 3, 2023

Imaweld® is thermoplastic elastomer tubing particularly designed to transfer critical fluid in pharmaceutical and biopharmaceutical applications.

Validation of ICON™ Automated Cell Counting and Viability Assay

whitePaper | August 10, 2022

Determination of cell viability and concentration using trypan blue exclusion is essential for biotherapeutic workflows, enabling optimisation of protocols, monitoring of changes to the culture environment, and selection of the best clones for culture progression.

COVID-19 Vaccines Production and Analytical Chemistry Solutions

whitePaper | February 2, 2022

Vaccines work by preparing a person’s immune system to recognize and defend itself against a specific disease.